After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and ...

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial ...

Armata Pharmaceuticals Logo (PRNewsfoto/Armata Pharmaceuticals, Inc.) Proceeds from the new financing transaction will be used to advance the Company's lead therapeutic phage candidates, ...

Eton Pharmaceuticals (ETON) announced that it has launched Galzin capsules. Galzin is FDA-approved for the maintenance treatment of patients ...

CBD-infused Products Market Expected to Grow at a CAGR of 30.6% from 2025 to 2032 REDDING, Calif., March 12, 2025 /PRNewswire/ -- According to a new market research report titled, 'CBD-infused ...

The 50 GW of new capacity was enough to power approximately 8.5 million households. This growth was accompanied by a significant expansion in domestic solar manufacturing, with module production ...

The government is targeting at least 500 GW of non-fossil power capacity by 2030, up from 165 GW currently. However, a lack of power transmission infrastructure is leading to delays in setting up ...

According to a new market research report titled, 'CBD-infused Products Market Size, Share, Forecast, & Trends Analysis by ...

Equinor has already scaled back its target for installed renewable energy capacity to 10-12 gigawatts (GW) by 2030, from 12-16 GW. While many shareholders have welcomed the shift, others have ...